Open Scanner

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Accelerate Diagnostics Inc

AXDX
Current price
1.18 USD -0.06 USD (-4.84%)
Last closed 1.18 USD
Sector Healthcare
Industry Medical Devices
Exchange NASDAQ
Capitalization 23 919 896 USD
Yield for 12 month +114.51 %
1Y
3Y
5Y
10Y
15Y
AXDX
21.11.2021 - 28.11.2021

Accelerate Diagnostics, Inc., an in vitro diagnostics company, provides solutions for the diagnosis of serious infections in the United States, Europe, and the Middle East. The company offers Accelerate Pheno system, an in vitro diagnostic platform for the identification and antibiotic susceptibility testing of pathogens associated with serious or health care-associated infections, including gram-positive and gram-negative organisms. It also provides the Accelerate PhenoTest, a test kit for the system, which provides identify and antibiotic susceptibility testing results for patients suspected of bacteremia or fungemia, both life-threatening conditions with high morbidity and mortality risk. The company was formerly known as Accelr8 Technology Corporation and changed its name to Accelerate Diagnostics, Inc. in December 2012. The company was incorporated in 1982 and is headquartered in Tucson, Arizona. Address: 3950 South Country Club Road, Tucson, AZ, United States, 85714

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

2 USD

P/E ratio

Dividend Yield

Current Year

+12 004 000 USD

Last Year

+12 752 000 USD

Current Quarter

+3 299 000 USD

Last Quarter

+2 921 000 USD

Current Year

+2 758 000 USD

Last Year

+3 303 000 USD

Current Quarter

+107 000 USD

Last Quarter

+799 000 USD

Key Figures AXDX

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA -54 031 000 USD
Operating Margin TTM -444.07 %
PE Ratio
Return On Assets TTM -62.15 %
PEG Ratio -0.55
Return On Equity TTM
Wall Street Target Price 2 USD
Revenue TTM 12 004 000 USD
Book Value -2.42 USD
Revenue Per Share TTM 1.07 USD
Dividend Share
Quarterly Revenue Growth YOY 11.5 %
Dividend Yield
Gross Profit TTM 3 303 000 USD
Earnings Share -5.52 USD
Diluted Eps TTM -5.52 USD
Most Recent Quarter III 2023
Quarterly Earnings Growth YOY
Profit Margin

Dividend Analytics AXDX

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History AXDX

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor 1:10
Payout Ratio
Last Split Date 12.07.2023
Dividend Date

Stock Valuation AXDX

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue 3.2772
Price Sales TTM 1.9927
Enterprise Value EBITDA -0.746
Price Book MRQ

Financials AXDX

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators AXDX

For 52 weeks

0.92 USD 11.9 USD
50 Day MA 2.86 USD
Shares Short Prior Month 448 315
200 Day MA 5.67 USD
Short Ratio 1.61
Shares Short 374 191
Short Percent 2.15 %

Dynamics of changes in the value of assets

Stocks


MSFT

MSFT

402.79 USD Microsoft Corporation -0.45 (-0.11%)
Detailed analytics

ETF funds


S

SX7EEX

11.59 EUR iShares EURO STOXX Banks 30-15 UCITS ETF (DE) 0 (0%)
Detailed analytics

Metals


Gold

2031.07 USD Gold +9.2 (+0.46%)
Detailed analytics